Wednesday, January 14, 2009

first prescription drug for growing eye lashes

The makers of Botox now bring you Latisse, the first federally approved drug for growing longer eye lashes. The New York Times reports:

The product has the same formula as Allergan’s eye drops for glaucoma, called Lumigan. It is one of several drugs in a category known as prostaglandin analogs, which are meant to reduce dangerous pressure in the eyeball. But as a side effect, the treatment tends to make the eyelashes of many patients longer and fuller.

Some medical experts say they worry that cosmetic customers may occasionally experience some of the glaucoma drug’s other side effects, which can include red, itchy eyes and changes in eyelid pigmentation. Some financial analysts, meanwhile, wonder how many people will want to spend $120 for a monthly dose of lash-lengthening Latisse.

But other analysts predict that in a world where people spend about $5 billion a year on mascara, Latisse could be the biggest thing to hit cosmetic medicine since, well, Botox. Sales for the cosmetic use of Botox were $600 million in 2007.

No comments: